News

STAT1h
FDA’s gene therapy turmoil unpacked
And other biotech news brought to you by The Readout.
STAT4h
Pharmalittle: We’re reading about FDA forcing out top gene therapy regulator, Gilead’s HIV challenges and more
And more pharma news updates from Pharmalittle.
Lilly to appeal as U.K. declines to endorse use of new Alzheimer’s drugs
Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...